Tankyrase regulates the TLR signaling pathways via PARylation-mediated degradation of 3BP2, and dysregulation of 3BP2 leads to autoinflammatory phenotypes, including severe inflammatory bowel disease (123, 124). This evidence concerns the gene SH3BP2 and inflammatory bowel disease.